Literature DB >> 2879897

Production, characterization, and immunohistochemical application of monoclonal antibodies to glutaminase purified from rat brain.

T Kaneko, Y Urade, Y Watanabe, N Mizuno.   

Abstract

Monoclonal antibodies were produced against phosphate-activated glutaminase (EC 3.5.1.2) as a marker for glutamatergic neurons: The enzyme was purified 1000-fold from rat brain mitochondria with a recovery of 27%. Upon SDS-PAGE the purified enzyme showed a single band up to 1.7 micrograms after the silver staining at molecular weight 62,000. Two monoclonal antibodies (IgMs) were produced; these absorbed more than 90% of glutaminase activity in rat brain homogenate. In immunoblotting after PAGE of the homogenate, the antibodies recognized only 1 protein band at the same position as that of the purified enzyme. Thus, the antibodies are specific and sufficient markers for glutaminase. Many neuronal cells in the rat brain were labeled immunohistochemically with these antibodies, but non-neuronal elements such as glial cells and vessels were not. Intense labeling was consistently observed in putative glutamatergic neurons such as pyramidal cells of layers V and VI in the cerebral neocortex. Intense staining was also seen in possible mossy fiber endings in the granular layer of the cerebellar cortex and in neurons giving off mossy fibers such as those in the pontine nuclei, pontine tegmental reticular nucleus of Bechterew, lateral reticular nucleus of the medulla oblongata, and external cuneate nucleus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2879897      PMCID: PMC6568863     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  15 in total

1.  Isolation of living neurons from human elderly brains using the immunomagnetic sorting DNA-linker system.

Authors:  Yoshihiro Konishi; Kristina Lindholm; Li-Bang Yang; Rena Li; Yong Shen
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Lasting changes in neuronal activation patterns in select forebrain regions of aggressive, adolescent anabolic/androgenic steroid-treated hamsters.

Authors:  Lesley A Ricci; Jill M Grimes; Richard H Melloni
Journal:  Behav Brain Res       Date:  2006-11-20       Impact factor: 3.332

3.  Deficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal Death.

Authors:  Yoshihiro Konishi; Li-Bang Yang; Ping He; Kristina Lindholm; Bai Lu; Rena Li; Yong Shen
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

4.  Optimizing optogenetic stimulation protocols in auditory corticofugal neurons based on closed-loop spike feedback.

Authors:  Charles-Henri Vila; Ross S Williamson; Kenneth E Hancock; Daniel B Polley
Journal:  J Neural Eng       Date:  2019-10-29       Impact factor: 5.379

5.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

Authors:  T Kawamata; I Tooyama; T Yamada; D G Walker; P L McGeer
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 6.  Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain.

Authors:  Silvia Mangia; Federico Giove; Mauro Dinuzzo
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

7.  15N n.m.r. measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat.

Authors:  K Kanamori; B D Ross
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

8.  Uptake and metabolism of glutamate and aspartate by astroglial and neuronal preparations of rat cerebellum.

Authors:  V L Rao; C R Murthy
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

9.  In vivo activity of glutaminase in the brain of hyperammonaemic rats measured by 15N nuclear magnetic resonance.

Authors:  K Kanamori; B D Ross
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

10.  Loss of glutaminase-positive cortical neurons in Alzheimer's disease.

Authors:  H Akiyama; P L McGeer; S Itagaki; E G McGeer; T Kaneko
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.